Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor

By Kimura Shinya   Niwa Tomoko   Hirabayashi Kazuko   Maekawa Taira  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite

Development of NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor

By Kimura Shinya   Niwa Tomoko   Hirabayashi Kazuko   Maekawa Taira  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 55-61

Springer Publishing Company

Access to resources Recommend Favorite

New Potent and Selective Inhibitor of Pim-1/3 Protein Kinases Sensitizes Human Colon Carcinoma Cells to Doxorubicin

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 9, 2014-11 ,pp. : 1228-1236

Bentham Science Publishers

Access to resources Recommend Favorite

Mutant B-Raf Kinase Inhibitors as Anticancer Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 16, Iss. 12, 2016-12 ,pp. : 1558-1575

Bentham Science Publishers

Access to resources Recommend Favorite

PH006, a novel and selective Src kinase inhibitor, suppresses human breast cancer growth and metastasis in vitro and in vivo

By Ma Jin-gui   Huang He   Chen Si-meng   Chen Yi   Xin Xian-liang   Lin Li-ping   Ding Jian   Liu Hong   Meng Ling-hua  

Breast Cancer Research and Treatment, Vol. 130, Iss. 1, 2011-11 ,pp. : 85-96

Springer Publishing Company

Access to resources Recommend Favorite